Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
United States of America et al v. INSYS Therapeutic Inc
Case Number:
2:13-cv-05861
Court:
Nature of Suit:
Other Statutes: False Claims Act
Judge:
Firms
Government Agencies
-
May 20, 2021
Ex-Insys CEO Escapes FCA Suit Over Opioid Bribes, For Now
A California federal judge on Wednesday tossed a False Claims Act suit over a scheme in which Insys executives allegedly bribed doctors to prescribe opioids, agreeing with the company's former CEO, who had argued that the allegations in the suit center on facts that were already publicly disclosed in other litigation.
-
June 06, 2019
Insys Chairman To Resign In Wake Of $225M Deal With Feds
Insys Therapeutics Inc. Chairman Steven Meyer will leave the post he's held since 2017, along with fellow board member Pierre Lapalme, the company said in a regulatory filing Thursday morning, a day after the drugmaker ended an opioid bribe investigation with the U.S. Department of Justice.
-
June 05, 2019
Insys To Pay $225M To End DOJ's Opioid Scheme Probe
Insys Therapeutics has agreed to a $225 million global settlement to end criminal and civil investigations by the federal government tied to allegations the pharmaceutical company bribed doctors to prescribe a powerful and addictive opioid spray, the U.S. Department of Justice said Wednesday.
-
August 08, 2018
Insys To Pay $150M To End DOJ Scrutiny Of Opioid-Rx Bribes
Opioid manufacturer Insys Therapeutics Inc. has agreed to pay at least $150 million for the U.S. Department of Justice to drop its criminal investigation and civil claims that the company bribed doctors to prescribe its under-the-tongue fentanyl spray, the company announced Wednesday.
-
May 15, 2018
Insys Bribed Docs To Write Opioid Scripts, DOJ, 6 States Say
The U.S. Department of Justice and six states have joined whistleblower litigation, unsealed Monday, accusing Insys Therapeutics of bribing doctors to prescribe the fentanyl painkiller Subsys off-label, purportedly costing the federal government tens of millions of dollars.